Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma

BMC Gastroenterology

Table 1 Dyspepsia score and Visual Analogue Scale of five major dyspeptic symptoms in scleroderma (SSc) patients and in dyspeptic and healthy controls

	SSc patients	Dyspeptic controls	Healthy controls	P (ANOVA)
Dyspepsia score	12.4 ± 1.0¹	23.7 ± 0.8^1,2	5.4 ± 0.8	0.000001
Appetite	397.8 ± 43.9	258.8 ± 33.53	313.6 ± 34.0	NS
Satiety	784.0 ± 40.0	828.5 ± 30.4	772.9 ± 31.0	NS
Nausea	18.6 ± 25.7	131.9 ± 19.7^1,2	11.0 ± 20.0	0.00003
Epigastric fullness	119.5 ± 36.0¹	363.0 ± 27.4^1,2	15.7 ± 27.8	0.000001
Epigastric pain	34.0 ± 26.0	136.2 ± 19.9^1,2	2.0 ± 20.2	0.00001

Data are expressed as means ± SE of Area Under Curve from 0 (fasting) to 120 minutes postprandially. Differences among groups were tested by Fisher's LSD Multiple Comparison test.
¹P < 0.05 vs controls; ²P < 0.05 vs SSc patients.

ISSN: 1471-230X